An increase of Gal-3 by >15% indicated a 50% higher relative hazard of adverse events (hospitalization and mortality) also after correction for age, sex, diabetes mellitus, left ventricular ejection fraction, renal function, medication, suggesting a significant prognostic value of repeated Gal-3 measurements [137]. This evidence concerns the gene LGALS3 and diabetes mellitus.